The treatment of challenging behaviour in intellectual disabilities: cost-effectiveness analysis.

@article{Romeo2009TheTO,
  title={The treatment of challenging behaviour in intellectual disabilities: cost-effectiveness analysis.},
  author={Renee Romeo and Martin Knapp and Peter Tyrer and Mike J Crawford and Patricia C Oliver-Africano},
  journal={Journal of intellectual disability research : JIDR},
  year={2009},
  volume={53 7},
  pages={
          633-43
        }
}
BACKGROUND Antipsychotic drugs are used in the routine treatment of adults with intellectual disabilities (ID) and challenging behaviour in the UK despite limited evidence of their effectiveness. There is no evidence on their cost-effectiveness. METHODS The relative cost-effectiveness of risperidone, haloperidol and placebo in treating individuals with an ID and challenging behaviour was compared from a societal perspective in a 26-week, double-blind, randomised controlled trial. Outcomes… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

A study on research status and development trend of cost-effectiveness analysis

  • 2012 International Conference on Information Management, Innovation Management and Industrial Engineering
  • 2012
VIEW 1 EXCERPT
CITES BACKGROUND

Treatment of Psychopathology in People with Intellectual and other Disabilities

  • Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 2012

References

Publications referenced by this paper.

The treatment of challenging behaviour in intellectual disabilities : cost - effectiveness analysis

P Tyrer, PC Oliver-Africano, +3 authors S Deb